Menu Search
Equities

Briacell Therapeutics Corp

BCT:TOR

Briacell Therapeutics Corp

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (CAD)0.88
  • Today's Change0.04 / 4.76%
  • Shares traded175.57k
  • 1 Year change-88.86%
  • Beta1.7178
Data delayed at least 15 minutes, as of Sep 20 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in USD

The one analyst offering a 12 month price target expects Briacell Therapeutics Corp share price to rise to 20.36 in the next year from the last price of 0.88.
High2,213.1%20.36
Med2,213.1%20.36
Low2,213.1%20.36

Earnings history & estimates in USD

On Jun 14, 2024, Briacell Therapeutics Corp reported 3rd quarter 2024 earnings of 0.11 per share. This result exceeded the -0.55 consensus loss of the one analyst covering the company and outperformed last year's 3rd quarter results by 0.43.
The next earnings announcement is expected on Oct 28, 2024.
Average growth rate-80.96%
Briacell Therapeutics Corp reported annual 2023 losses of -1.30 per share on Oct 25, 2023.
Average growth rate+24.86%
More ▼

Revenue history & estimates in USD

BriaCell Therapeutics Corp. did not report revenues for the 3rd quarter 2024. However, during the 3rd quarter of the prior year the company reported revenues of 0.00.
Average growth rate0.00%
BriaCell Therapeutics Corp. did not report revenues for the full year 2023. However, during the prior year the company reported revenues of 0.00.
Average growth rate0.00%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.